US EditionBillionaire Mehta Brothers’ Torrent To Buy Stake In India’s JB Pharma In $1.4 Billion Deal
- On June 29, 2025, Torrent Pharmaceuticals disclosed that it had finalized deals with KKR to purchase a controlling interest in JB Chemicals and Pharmaceuticals, with the intention to consolidate the two companies through a merger.
- The deal follows KKR's decision to sell its stake in JB Pharma, valuing the company at 25,689 crore rupees and reflecting JB Pharma's fast growth and profit increase.
- Torrent will buy a 46.39% stake at 1,600 rupees per share, acquire up to 2.8% from employees, and make a mandatory open offer for an additional 26% at 1,639.18 rupees per share.
- Samir Mehta, Executive Chairman of Torrent, highlighted that the merger creates strong opportunities to grow both revenue and profit margins, while JB Pharma CEO Nikhil Chopra underscored the partnership’s role in expanding healthcare access.
- The transaction requires regulatory approvals and aims to strengthen Torrent’s market share in India, diversify its platform, and merge JB Pharma's chronic segment brands with Torrent.
Insights by Ground AI
Does this summary seem wrong?
29 Articles
29 Articles
All
Left
3
Center
6
Right
6
Torrent Pharma's Strategic Acquisition Boost
Torrent Pharma's Strategic Acquisition Boost In a significant move within the pharmaceutical sector, India's Torrent Pharmaceuticals announced its plan to acquire a 46.39% controlling stake in JB Chemicals and Pharmaceuticals. The stake is being purchased from the New York-based investment firm KKR.The acquisition, part of a merger plan outlined by the companies, represents a strategic effort to consolidate operations. The joint announcement fro…
·India
Read Full Article
Coverage Details
Total News Sources29
Leaning Left3Leaning Right6Center6Last UpdatedBias Distribution40% Center, 40% Right
Bias Distribution
- 40% of the sources are Center, 40% of the sources lean Right
40% Right
L 20%
C 40%
R 40%
Factuality
To view factuality data please Upgrade to Premium
